Literature DB >> 30678833

Prognostic Importance of Hippocampal Atrophy in Patients With Chronic Heart Failure.

Takeshi Niizeki1, Tadateru Iwayama2, Eiichiro Ikeno2, Masafumi Watanabe3.   

Abstract

Mild cognitive impairment (MCI) impedes a patient's decision-making ability to support self-care and is associated with increased mortality in patients with chronic heart failure (CHF). Thus, screening for MCI is very important. The assessment of hippocampal atrophy using magnetic resonance imaging can effectively diagnose early MCI. The purpose of this study was to assess the prevalence and prognostic significance of hippocampal atrophy using magnetic resonance imaging in patient with CHF. Of the 491 patients with CHF included in the study, 170 demonstrated hippocampal atrophy. Patients with hippocampal atrophy were older, and showed a higher rate of renal dysfunction and cardiac events than patients without hippocampal atrophy. A total of 180 cardiac events occurred during the follow-up period. A Cox proportional hazards regression model and Kaplan-Meier analysis showed that hippocampal atrophy was significantly associated with cardiac events. In conclusion, hippocampal atrophy is a significant and independent predictor of poor prognosis in patients with CHF and can aid risk stratification of these patients.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Year:  2019        PMID: 30678833     DOI: 10.1016/j.amjcard.2018.12.035

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

Review 1.  Autonomic Neural Circuit and Intervention for Comorbidity Anxiety and Cardiovascular Disease.

Authors:  Xuanzhao Chen; Li Xu; Zeyan Li
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

2.  Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients.

Authors:  Jan Traub; Markus Otto; Roxane Sell; Dennis Göpfert; György Homola; Petra Steinacker; Patrick Oeckl; Caroline Morbach; Stefan Frantz; Mirko Pham; Stefan Störk; Guido Stoll; Anna Frey
Journal:  Alzheimers Res Ther       Date:  2022-10-10       Impact factor: 8.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.